Gallium dimercaptosuccinate as a novel tumor imaging agent

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 137, 424 165, 424 96, 534 10, A61K 5100, A61M 3614

Patent

active

056394390

ABSTRACT:
Novel tumor imaging agents in which the dimercaptosuccinic acid was dissolved in phosphate buffer and labelled with radioisotope gallium. The product of gallium dimercaptosuccinate has been characterized by a variety of experiments including serum stability, biodistribution and imaging experiment. As the results, the compound of gallium dimercaptosuccinate has been confirmed as a novel radiopharmaceutical for tumor imaging agent.

REFERENCES:
patent: Re31463 (1983-12-01), Loberg et al.
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4233285 (1980-11-01), Winchell et al.
patent: 4264468 (1981-04-01), Neirinckx et al.
patent: 4361544 (1982-11-01), Goldenberg
patent: 4448763 (1984-05-01), Triplett
patent: 4720379 (1988-01-01), Heyl et al.
patent: 5019369 (1991-05-01), Presant et al.
patent: 5079346 (1992-01-01), Kung
patent: 5399338 (1995-03-01), Born et al.
patent: 5428139 (1995-06-01), Kiefer et al.
Saji et al (1980). Radioisotopes, vol. 29, No. 1, pp. 7-12 "Enhancement of .sup.67 Ga-Citrate Tumor-to-Blood Ratios by Chelating Agent".
Green et al. "Gallium-68 1,1,1-tris (5-methoxysalicylaldiminomethyl) Ethane: A Potential Tracer for Evaluation of Regional Myocardial Blood Flow", The Journal of Nuclear Medicine, 26, pp. 170-180 (1995).
Burns et al. "Reversal of Gallium Arsenide-Induced Suppression of the Antibody Response by a Mixed Disulfide Metabolite of Meso -2,3-dimelcaptosuccinic acid." The Journal of Pharmacology and Experimental Therapeutics, vol. 264, No. 2, pp. 695-700.
Green et al, "Gallium Radiopharmaceutical Chemistry," Nucl. Med. Bio. vol. 6, No. 5, pp. 435-448 (1989).
Chemical Principles, .COPYRGT.1985, p. 237. "The Periodic Table and the Properties of Metals" by Masterton et al. The Merck Index, 9th edition, p. 560, compound 4191.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gallium dimercaptosuccinate as a novel tumor imaging agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gallium dimercaptosuccinate as a novel tumor imaging agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gallium dimercaptosuccinate as a novel tumor imaging agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2155823

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.